C

Haemonetics Corporation HAE

$122.94 $0.230.19% NYSE
Recommendation
Dividend Power Score
Day's Range
$121.86$126.09
Latest Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
EPS (TTM)
My Lists My Alerts
Access our Premium Ratings
Get Access

HAE Rating

Reward
Risk

HAE Rating Factors

Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index

HAE Company Overview

Haemonetics Corporation is a U.S.-based medical technology company focused on blood and plasma collection, hospital transfusion management, and hemostasis management solutions. The company operates within the broader healthcare equipment and medical devices industry, serving blood centers, plasma collection operators, hospitals, surgical centers, and healthcare providers. Its core revenue drivers include plasma collection systems, blood management technologies, disposables used in recurring clinical procedures, and software platforms supporting transfusion and patient blood management workflows.

The company’s primary business segments include Plasma, Blood Center, and Hospital operations. Haemonetics has developed a strong competitive position through its installed base of automated collection devices, recurring consumables revenue model, and long-standing relationships with plasma collection companies and healthcare institutions. Founded in 1971 and headquartered in Boston, Massachusetts, the company initially focused on automated blood collection technologies and later expanded through acquisitions and product development into hospital blood management, surgical technologies, and digital clinical software platforms.

Data compiled by narrative technology. May contain errors.
Sector

HAE Income Statement

Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)

HAE Balance Sheet

Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)

HAE Cash Flow

Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)

HAE Price History

Loading...
52-Week Range89% of range
Current
$122.94
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return

HAE Valuation

Market Cap
Market Cap Rank
#3,446
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)

HAE Dividends and Shares

Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--

HAE Corporate Info

Phone Number
781 848 7100
Address
125 Summer Street
Boston, MA 02110
Country
Year Founded

HAE Filings

Filing Date
Thursday, November 5, 2026
Period Date
Wednesday, September 30, 2026
Next Filing
Week of Feb 1 and 5 (est)

HAE Headlines